1233353-86-0
Chemical Structure
PCSK9-IN-29
- CAS No.: 1233353-86-0
- Formula:C26H26FNO6S
- Molecular Weight:499.55
InChIKey: HEAINOSHEFYFCX-UHFFFAOYSA-N
SMILES: O=S(OC1=C(CN2CCC3=CC(OC)=C(C=C3C2C4)OC)C4=CC=C1OC)(C5=CC(F)=CC=C5)=O
Biological Activity:
PCSK9-IN-29 is a lipid-lowering agent. PCSK9-IN-29 can increase low-density lipoprotein receptor (LDLR) protein expression and decrease PCSK9 protein expression in hepG2 cells. PCSK9-IN-29 can reduce the levels of serum LDL-C, TC, and liver enzyme ALT in crab eating macaques fed a high-fat diet, lower body weight and fat, and increase bone mineral content. PCSK9-IN-29 can be used for research on non-alcoholic fatty liver disease and obesity[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PCSK9-IN-29 | 99.44% | PCSK9-IN-29 is a lipid-lowering agent. PCSK9-IN-29 can increase low-density lipoprotein receptor (LDLR) protein expression and decrease PCSK9 protein expression in hepG2 cells. PCSK9-IN-29 can reduce the levels of serum LDL-C, TC, and liver enzyme ALT in crab eating macaques fed a high-fat diet, lower body weight and fat, and increase bone mineral content. PCSK9-IN-29 can be used for research on non-alcoholic fatty liver disease and obesity. |
||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
